These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 39106254)
1. Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19. Holton SE; Mitchem M; Chalian H; Pipavath S; Morrell ED; Bhatraju PK; Hamerman JA; Speake C; Malhotra U; Wurfel MM; Ziegler SE; Mikacenic C PLoS One; 2024; 19(8):e0285638. PubMed ID: 39106254 [TBL] [Abstract][Full Text] [Related]
2. Mediators of monocyte chemotaxis and matrix remodeling are associated with the development of fibrosis in patients with COVID-19. Holton SE; Mitchem M; Pipavath S; Morrell ED; Bhatraju PK; Hamerman JA; Speake C; Malhotra U; Wurfel MM; Ziegler S; Mikacenic C medRxiv; 2023 May; ():. PubMed ID: 37205332 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary redox imbalance drives early fibroproliferative response in moderate/severe coronavirus disease-19 acute respiratory distress syndrome and impacts long-term lung abnormalities. Yang C; Tan Y; Li Z; Hu L; Chen Y; Zhu S; Hu J; Huai T; Li M; Zhang G; Rao D; Fei G; Shao M; Ding Z Ann Intensive Care; 2024 May; 14(1):72. PubMed ID: 38735020 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 viremia but not respiratory viral load is associated with respiratory complications in patients with severe COVID-19. Chen L; Olson LB; Naqvi IA; Sullenger BA; Que LG; Denny TN; Kraft BD BMC Pulm Med; 2024 Jul; 24(1):366. PubMed ID: 39080682 [TBL] [Abstract][Full Text] [Related]
5. Association between active cytomegalovirus infection and lung fibroproliferation in adult patients with acute respiratory distress syndrome: a retrospective study. Zhang Z; Li R; Chen Y; Zhang J; Zheng Y; Xu M; Liang J; Li J; Huang Y; Xu Y; He W; Liu X; Li Y BMC Infect Dis; 2022 Oct; 22(1):788. PubMed ID: 36241980 [TBL] [Abstract][Full Text] [Related]
6. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities. Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572 [TBL] [Abstract][Full Text] [Related]
7. The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up. Zhang S; Boers LS; de Brabander J; van den Heuvel LB; Blok SG; Kullberg RFJ; Smids-Dierdorp BS; Dekker T; Aberson HL; Meijboom LJ; Vlaar APJ; Heunks L; Nossent EJ; van der Poll T; Bos LDJ; Duitman J; Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L7-L18. PubMed ID: 37933449 [TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981 [TBL] [Abstract][Full Text] [Related]
9. Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome. Forel JM; Guervilly C; Farnarier C; Donati SY; Hraiech S; Persico N; Allardet-Servent J; Coiffard B; Gainnier M; Loundou A; Sylvestre A; Roch A; Bourenne J; Papazian L PLoS One; 2018; 13(11):e0206105. PubMed ID: 30395619 [TBL] [Abstract][Full Text] [Related]
10. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target. Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V Front Immunol; 2021; 12():687397. PubMed ID: 34671341 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135 [TBL] [Abstract][Full Text] [Related]
13. Detection of fibroproliferation by chest high-resolution CT scan in resolving ARDS. Burnham EL; Hyzy RC; Paine R; Kelly AM; Quint LE; Lynch D; Curran-Everett D; Moss M; Standiford TJ Chest; 2014 Nov; 146(5):1196-1204. PubMed ID: 24722949 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Grasselli G; Tonetti T; Protti A; Langer T; Girardis M; Bellani G; Laffey J; Carrafiello G; Carsana L; Rizzuto C; Zanella A; Scaravilli V; Pizzilli G; Grieco DL; Di Meglio L; de Pascale G; Lanza E; Monteduro F; Zompatori M; Filippini C; Locatelli F; Cecconi M; Fumagalli R; Nava S; Vincent JL; Antonelli M; Slutsky AS; Pesenti A; Ranieri VM; Lancet Respir Med; 2020 Dec; 8(12):1201-1208. PubMed ID: 32861276 [TBL] [Abstract][Full Text] [Related]
15. Timing and causes of death in severe COVID-19 patients. de Roquetaillade C; Bredin S; Lascarrou JB; Soumagne T; Cojocaru M; Chousterman BG; Leclerc M; Gouhier A; Piton G; Pène F; Stoclin A; Llitjos JF Crit Care; 2021 Jun; 25(1):224. PubMed ID: 34193220 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801 [TBL] [Abstract][Full Text] [Related]
17. Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome. Hamon A; Scemama U; Bourenne J; Daviet F; Coiffard B; Persico N; Adda M; Guervilly C; Hraiech S; Chaumoitre K; Roch A; Papazian L; Forel JM Ann Intensive Care; 2019 Mar; 9(1):42. PubMed ID: 30919111 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A; Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674 [TBL] [Abstract][Full Text] [Related]
20. Early versus late tracheostomy in critically ill COVID-19 patients. Szafran A; Dahms K; Ansems K; Skoetz N; Monsef I; Breuer T; Benstoem C Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015532. PubMed ID: 37982427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]